Publication | Open Access
Repeatability and Reproducibility of Foveal Avascular Zone Area Measurement on Normal Eyes by Different Optical Coherence Tomography Angiography Instruments
32
Citations
16
References
2018
Year
Foveal Avascular ZoneEngineeringRetinaMedical ImagingOphthalmologyVascular ImageBiomedical ImagingVascular ImagingOct DeviceNormal EyesOptical Coherence TomographyMedical Image ComputingMedicineArbitrary Segmentation LinesRetinal BiologyTomographyRadiology
<b><i>Purpose:</i></b> To compare the foveal avascular zone (FAZ) area measurements produced by different optical coherence tomography angiography (OCTA). <b><i>Methods:</i></b> Healthy enrolled volunteers underwent OCTA using 2 different devices: Spectralis HRA+OCTA (Heidelberg Engineering, Heidelberg, Germany) and RS-3000 Advance (Nidek, Gamagori, Japan). Two graders measured FAZ in both superficial (SCP) and deep (DCP) retinal capillary plexuses. The SCP and DCP en face images were visualized automatically segmenting 2 separate slabs defined by the arbitrary segmentation lines created by the software of each OCT device. One grader repeated each measure twice. <b><i>Results:</i></b> Fifty-nine eyes were included. The mean FAZ was 0.33 ± 0.09 mm<sup>2</sup> at the SCP and 0.57 ± 0.17 mm<sup>2</sup> at the DCP measured with RS-3000 versus 0.30 ± 0.08 and 0.35 ± 0.08 mm<sup>2</sup>, respectively, measured with Spectralis. The measurements of the 2 devices were significantly different (<i>p</i> &#x3c; 0.0001). The intraoperator agreement was excellent at the SCP (intraclass correlation coefficient, ICC: 0.97 with Spectralis and 0.96 with RS-3000). At the DCP, it was good with Spectralis and fair with RS-3000 (ICC: 0.85 and 0.64, respectively). The interoperator agreement was excellent for Spectralis and good for RS-3000 at the SCP (ICC: 0.97 and 0.93, respectively). It was good at the DCP with both devices (ICC: 0.74 with RS-3000 and 0.81 with Spectralis). <b><i>Conclusions:</i></b> FAZ measurements obtained with different OCTA devices differ. These findings should be considered in follow-up studies of patients with retinal vascular diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1